Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS

NCT ID: NCT03983681

Last Updated: 2025-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-26

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with Multiple Sclerosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in persons with Multiple Sclerosis (MS). The study is designed to research how well this technique can help people with MS improve their memory and their ability to function better in everyday life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators
Participants will be blind as to which treatment group they are being placed. Study staff conducting baseline and follow-up assessments will also be blind as to which group participants are placed. Study staff conducting intervention sessions will be blind to participants' baseline and follow-up assessment performance.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

The experimental group will receive memory enhancement exercises administered twice a week for 4 weeks (8 training sessions).

Group Type EXPERIMENTAL

Strategy-Based Training to Enhance Memory (STEM)

Intervention Type BEHAVIORAL

Protocol designed to improve memory functioning in individuals with neurological injuries administered for 4 weeks (8 training sessions).

Control group

The control group will receive placebo memory enhancement exercises administered twice a week for 4 weeks (8 training sessions).

Group Type PLACEBO_COMPARATOR

Placebo control exercises

Intervention Type BEHAVIORAL

Placebo control memory exercises will be administered for 4 weeks (8 training sessions).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Strategy-Based Training to Enhance Memory (STEM)

Protocol designed to improve memory functioning in individuals with neurological injuries administered for 4 weeks (8 training sessions).

Intervention Type BEHAVIORAL

Placebo control exercises

Placebo control memory exercises will be administered for 4 weeks (8 training sessions).

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of Multiple Sclerosis
* Ability to read and speak English fluently
* Difficulties with learning and memory skills

Exclusion Criteria

* Prior diagnosis of stroke or other neurological injury/disease
* Flare up of symptoms within a month of study participation
* History of significant psychiatric illness (e.g., bipolar disorder, schizophrenia, psychosis) or current diagnosis of Major Depressive Disorder, Schizophrenia, Bipolar Disorder I or II
* Current significant alcohol or substance abuse
* Taking exclusionary medication (study team will review medications)

For Optional MRI:

* Pacemaker or other implanted electrical device, brain stimulator, aneurysm clip (metal clips on the wall of a large artery), metallic prostheses (including metal pins and rods, heart valves, and internal hearing aids \[cochlear implants\]), permanent eyeliner, implanted delivery pumps, or shrapnel fragments.
* Dental implants
* Left-handed
Minimum Eligible Age

18 Years

Maximum Eligible Age

59 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kessler Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nancy Chiaravalloti

Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nancy D Chiaravalloti, PhD

Role: PRINCIPAL_INVESTIGATOR

Kessler Foundation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kessler Foundation

East Hanover, New Jersey, United States

Site Status

Kessler Rehabilitation Center

Marlton, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R-1045-18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.